Idarubicin is an anthracycline antineoplastic agent used primarily to treat acute myeloid leukemia, breast cancer, lymphomas, and sarcomas. As a synthetic analog of daunorubicin, it is noted for its ability… Read more









Idarubicin is an anthracycline antineoplastic agent used primarily to treat acute myeloid leukemia, breast cancer, lymphomas, and sarcomas. As a synthetic analog of daunorubicin, it is noted for its ability to intercalate DNA and inhibit topoisomerase II, often with a more favorable cardiotoxicity profile. This category provides essential reference standards for the analysis of the drug substance, including synthetic impurities, degradation products, and metabolites such as idarubicinol and the idarubicin aglycone. These high-quality reference materials are critical for laboratories performing impurity profiling, method validation, and stability testing. Additionally, the collection includes stable isotope-labeled compounds, such as deuterium and 13C-labeled versions of the drug and its primary metabolite, which serve as internal standards for accurate quantification in complex biological matrices and pharmacokinetic studies.